Nobel Biocare Annual General Meeting 2001

Nobel Biocare Annual General Meeting 2001 The Annual General Meeting on April 20, 2001, approved a dividend of SEK 2.40 or a total of SEK 60,803,846. The record day for this dividend will be 25 April 2001. Payment is expected to be made by VPC AB (the Swedish Securities Registration Centre) on 30 April 2001. The following board members were re-elected: Jan Ekberg, Jack Forsgren, Jan Kvarnström, Ernst Thomke, and Heliane Canepa. Ernst Zaengerle was elected as new board member. At the board meeting following the election, Ernst Thomke was elected as Chairman of the Board and Heliane Canepa as Deputy Chairman. Furthermore, it was decided to establish an option program for about 125 executives. The program runs for three years. The amount of options to current executives is 796 000 maximally, and for possible executives who join the company at a later date an extra 400 000. The program conveys a maximal dilution of about 4,5 percent, with effect gradually from 2004 to 2006. The interim report for the first quarter was published 20 April 2001. The interim report for the first six months will be issued 14 August 2001 and the interim report relating to the first nine months will be published 23 October 2001. Gothenburg, 23 April 2001 NOBEL BIOCARE AB For further information please contact: Jan H Johansson, General Counsel, Nobel Biocare AB, telephone +46 031 81 88 29. ------------------------------------------------------------ This information was brought to you by BIT http://www.bit.se The following files are available for download: http://www.bit.se/bitonline/2001/04/23/20010423BIT00230/bit0001.doc http://www.bit.se/bitonline/2001/04/23/20010423BIT00230/bit0002.pdf

About Us

Nobel Biocare is the world leader in innovative esthetic dental solutions with the brands Brånemark System® ,Replace® Select and Procera®.Nobel Biocare has around 1,300 employees and, in 2001 net sales totaled SEK 2 663 million. The company's headquarters are located in Gothenburg, Sweden. Nobel Biocare has its own sales organizations in 27 countries. The shares of the parent company Nobel Biocare Holding AG are listed on both the SWX Swiss Exchange and the Stockholm Stock Exchange.

Subscribe